Board
Screen
Heat
Cal
Watch
News
Blog
TV
Home
/
GSK
Home
/
GSK

NYSE
$51.04
$51.04

Overview

Price performance
Low
$50.08
High
$51.28
Market open. Last updated: Nov 4, 2026, 8:22 PM UTC
$
51.04
2.34 (4.80%)
Average, 50 days
$49.30
$52.35
Open
$50.83
Previous close
$48.70
52-week high
$61.70
Feb 18, 2026 (9 months ago)
52-week low
$45.81
Nov 20, 2025 (1 year ago)
11.42%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
103.45B
Volume
3 988 635
Total Return (3M)
-0.95%
Total Return (1Y)
9.01%
11.75
Sector
Healthcare
Links
Tags
Healthcare
Drug Manufacturers - General
NYSE
GB
Website
gsk.com
Socials
About
GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty and general medicines for markets across the United Kingdom, the United States, and internationally. The company's operations are organized into two key divisions: Commercial Operations and Total R&D. Its extensive vaccine portfolio includes immunizations against shingles, meningitis, respiratory syncytial virus (RSV), seasonal and pandemic influenza, and polio. Beyond preventative care, GSK provides diverse therapeutic products covering critical areas such as HIV, oncology, respiratory and immunology conditions, and other specialized medical fields. This also encompasses inhaled treatments for chronic respiratory ailments like asthma and chronic obstructive pulmonary disease (COPD), along with antibiotics for various infections. Innovation at GSK is frequently driven by strategic partnerships. Notable collaborations include an agreement with CureVac to advance mRNA-based influenza vaccines, and alliances with Wave Life Sciences and Elsie Biotechnologies focused on developing oligonucleotide platforms. Furthermore, GSK has established two distinct strategic collaborations with Relation to progress therapeutics for fibrotic diseases and osteoarthritis. The company is also engaged in a multi-target strategic alliance aimed at developing pioneering treatments for individuals suffering from Parkinson's disease, and a partnership with Flagship Pioneering to identify novel medicines and vaccines.

Frequently asked questions

GSK · GSK plc

01What is GSK plc stock price today?

The current price of GSK is $51.04 — it has increased by 4.80% since the previous close. Data as of Nov 4, 2026.

02Is GSK plc stock price growing?

GSK is up 2.41% over the past week, up 8.53% over the past month and up 9.01% over the past year. The price is below its 200-day moving average of $52.35.

03What is GSK plc market cap?

GSK plc has a market capitalization of $103.45B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

04How volatile is GSK stock?

In the latest trading session GSK moved between $50.08 and $51.29, a range of 2.36% of its current price.

05What are GSK stock 52-week high and low?

Over the past 52 weeks GSK has traded between $45.81 and $61.70. The current price is 17.28% below its 52-week high.

Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.